Beyond Air, Inc. (XAIR)
USD 0.24
(-0.49%)
USD 0.24
(-0.49%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 14.72 Million USD | 12167.5% |
| 2023 | 2.44 Million USD | 7.11% |
| 2022 | 2.27 Million USD | -63.6% |
| 2021 | 6.26 Million USD | 40.05% |
| 2020 | 4.47 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 2.89 Million USD | 86.53% |
| 2016 | 1.55 Million USD | 15420.0% |
| 2015 | 10 Thousand USD | -23.08% |
| 2014 | 13 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 FY | 14.72 Million USD | 503.07% |
| 2024 Q1 | 15.97 Million USD | 11357.5% |
| 2024 Q2 | 16.13 Million USD | 2.15% |
| 2024 Q3 | 14.38 Million USD | 2.39% |
| 2024 Q4 | 14.72 Million USD | 2.37% |
| 2023 FY | 2.44 Million USD | 7.11% |
| 2023 Q2 | 2.29 Million USD | -4.3% |
| 2023 Q3 | 2.42 Million USD | 5.76% |
| 2023 Q4 | 2.44 Million USD | 0.78% |
| 2023 Q1 | 2.39 Million USD | 5.0% |
| 2022 Q2 | 6.22 Million USD | -0.04% |
| 2022 Q4 | 2.27 Million USD | -3.51% |
| 2022 FY | 2.27 Million USD | -63.6% |
| 2022 Q1 | 6.22 Million USD | -0.56% |
| 2022 Q3 | 2.36 Million USD | -62.04% |
| 2021 Q2 | 4.7 Million USD | 0.25% |
| 2021 Q3 | 4.71 Million USD | 0.24% |
| 2021 Q4 | 6.26 Million USD | 32.68% |
| 2021 FY | 6.26 Million USD | 40.05% |
| 2021 Q1 | 4.69 Million USD | 5.03% |
| 2020 Q2 | 169 Thousand USD | -5.73% |
| 2020 FY | 4.47 Million USD | 0.0% |
| 2020 Q4 | 4.47 Million USD | 2853.18% |
| 2020 Q3 | 151.38 Thousand USD | -10.43% |
| 2020 Q1 | 179.27 Thousand USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | -100.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q2 | 2.54 Million USD | 0.0% |
| 2017 Q4 | - USD | -100.0% |
| 2017 FY | 2.89 Million USD | 86.53% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q3 | 2.89 Million USD | 13.66% |
| 2016 Q3 | 10 Thousand USD | 0.0% |
| 2016 Q4 | 10 Thousand USD | 0.0% |
| 2016 FY | 1.55 Million USD | 15420.0% |
| 2016 Q1 | 969 Thousand USD | 0.0% |
| 2016 Q2 | - USD | -100.0% |
| 2015 Q3 | 568 Thousand USD | 0.0% |
| 2015 Q2 | 568 Thousand USD | 0.0% |
| 2015 FY | 10 Thousand USD | -23.08% |
| 2015 Q4 | 969 Thousand USD | 70.6% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | 13 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 59.224% |
| BrainsWay Ltd. | 239 Thousand USD | -6059.414% |
| Cerus Corporation | 59.79 Million USD | 75.381% |
| Envoy Medical, Inc. | 404 Thousand USD | -3543.812% |
| electroCore, Inc. | 537 Thousand USD | -2641.341% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -122575.0% |
| IceCure Medical Ltd | 376 Thousand USD | -3815.16% |
| Inogen, Inc. | 18.27 Million USD | 19.425% |
| OrthoPediatrics Corp. | 13.45 Million USD | -9.377% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -7297.487% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -3947.3% |
| MaxCyte, Inc. | 17.96 Million USD | 18.076% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -26527.957% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 84.189% |
| PAVmed Inc | 2.96 Million USD | -397.331% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -136.901% |
| RxSight, Inc. | 1.21 Million USD | -1115.607% |
| Sight Sciences, Inc. | 31.7 Million USD | 53.573% |
| SI-BONE, Inc. | 36.06 Million USD | 59.182% |
| TELA Bio, Inc. | 40.51 Million USD | 63.665% |
| Treace Medical Concepts, Inc. | 53 Million USD | 72.229% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -867.85% |
| Acutus Medical, Inc. | 32.65 Million USD | 54.918% |
| Talis Biomedical Corporation | 16.78 Million USD | 12.302% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -263.931% |
| CVRx, Inc. | 30.38 Million USD | 51.547% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -1347.592% |
| Bioventus Inc. | 366.99 Million USD | 95.989% |
| Venus Concept Inc. | 70.79 Million USD | 79.205% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -1083.36% |
| LivaNova PLC | 568.54 Million USD | 97.411% |
| 908 Devices Inc. | 3.92 Million USD | -274.675% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 97.119% |
| Nemaura Medical Inc. | 3.08 Million USD | -376.77% |
| NeuroPace, Inc. | 56.95 Million USD | 74.153% |
| LENSAR, Inc. | 1.75 Million USD | -741.2% |
| Apyx Medical Corporation | 33.18 Million USD | 55.64% |
| Cutera, Inc. | 418.69 Million USD | 96.484% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 2.147% |
| BioSig Technologies, Inc. | 103 Thousand USD | -14192.233% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 45.283% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -47.965% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.009% |
| Axonics, Inc. | 25.84 Million USD | 43.03% |
| Outset Medical, Inc. | 134.59 Million USD | 89.063% |
| IRIDEX Corporation | 1.75 Million USD | -740.72% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 71.326% |
| IRadimed Corporation | 1.61 Million USD | -811.472% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -8264.205% |
| INVO Bioscience, Inc. | 6.77 Million USD | -117.249% |
| Telesis Bio, Inc. | 5.26 Million USD | -179.389% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -146.53% |
| Varex Imaging Corporation | 464.2 Million USD | 96.829% |
| Quipt Home Medical Corp. | 60.82 Million USD | 75.796% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -2403.571% |
| Pulmonx Corporation | 35.08 Million USD | 58.047% |
| Dynatronics Corporation | 3.25 Million USD | -351.775% |
| Modular Medical, Inc. | 817 Thousand USD | -1701.836% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -9649.007% |
| Semler Scientific, Inc. | 70 Thousand USD | -20930.0% |
| InMode Ltd. | 6.61 Million USD | -122.607% |
| Bruker Corporation | 1.14 Billion USD | 98.714% |
| Cytosorbents Corporation | 2.54 Million USD | -478.916% |
| DexCom, Inc. | 2.57 Billion USD | 99.428% |
| Align Technology, Inc. | 96.96 Million USD | 84.819% |
| Viveve Medical, Inc. | 5.12 Million USD | -187.295% |
| ZimVie Inc. | 508.79 Million USD | 97.107% |
| Movano Inc. | 15.00 USD | -98139900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 18.781% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 96.307% |
| Profound Medical Corp. | 4.97 Million USD | -195.934% |
| Insulet Corporation | 1.36 Billion USD | 98.923% |
| enVVeno Medical Corporation | 1.06 Million USD | -1283.553% |
| Surmodics, Inc. | 29.4 Million USD | 49.937% |
| iCAD, Inc. | 273 Thousand USD | -5292.308% |
| Nuwellis, Inc. | 221 Thousand USD | -6561.086% |
| Biotricity, Inc. | 10.85 Million USD | -35.605% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 57.88% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -2165.637% |
| InspireMD, Inc. | 1.03 Million USD | -1318.208% |
| PAVmed Inc. | 2.96 Million USD | -397.331% |
| BIOLASE, Inc. | 13.98 Million USD | -5.263% |
| FONAR Corporation | 37.92 Million USD | 61.188% |
| AxoGen, Inc. | 46.6 Million USD | 68.412% |
| Vivani Medical, Inc. | 19.31 Million USD | 23.777% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 67.002% |
| Inari Medical, Inc. | 30.35 Million USD | 51.504% |
| UFP Technologies, Inc. | 28 Million USD | 47.425% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -3291.584% |
| Tenon Medical, Inc. | 428 Thousand USD | -3339.486% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -1369.162% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -584.004% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.297% |
| Sintx Technologies, Inc. | 3.68 Million USD | -299.268% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 60.452% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -2403.571% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -2369.966% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 98.35% |
| TransMedics Group, Inc. | 506.2 Million USD | 97.092% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -2325.206% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -15817.176% |
| Hyperfine, Inc. | 64 Thousand USD | -22901.563% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 92.2% |
| Biomerica, Inc. | 459 Thousand USD | -3107.19% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -3175.096% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -7648.425% |
| Silk Road Medical, Inc | 75.62 Million USD | 80.534% |